Aerospace

Engineered semiconductor materials for imaging & power generation
Engineered semiconductor materials for imaging & power generation

Imaging and sensing

Specialty semiconductor materials for medical imaging and diagnosis
Specialty semiconductor materials for medical imaging and diagnosis

Industrial materials

Specialty Alloys for Industrial Applications
Specialty Alloys for Industrial Applications

Health and pharmaceutical

Active pharmaceutical & dietary precursors for human & animal health
Active pharmaceutical & dietary precursors for human & animal health

Catalytic and Extractive

Catalytic and Extractive Materials for oil, gas and mining industries
Catalytic and Extractive Materials for oil, gas and mining industries

Renewable energy

Semiconductor materials for renewable power generation
Semiconductor materials for renewable power generation

Recycling and refining

Global recycling & refining assets & capabilities
Global recycling & refining assets & capabilities

Who we are

5N Plus is a leading global producer of engineered materials and specialty chemicals with integrated recycling and refining assets to manage the sustainability of its business model. The Company is headquartered in Montreal, Québec, Canada and operates R&D, manufacturing and commercial centers in several locations in Europe, the Americas and Asia. 5N Plus deploys a range of proprietary and proven technologies to manufacture products which are used as enabling precursors by its customers in a number of advanced electronics, optoelectronics, pharmaceutical, health, renewable energy and industrial applications. Many of the materials produced by 5N Plus are critical for the functionality and performance of the products and systems produced by its customers, many of whom are leaders within their industry.

5N21 Strategic Plan

Updated as of 04-2019
Download

Brochure

Unlocking Opportunities
Download

News

5N Plus Acquires Stake in Microbion and Secures Drug Substance Manufacturing Rights
Montreal, Québec and Bozeman, Montana, January 12, 2021 –– 5N Plus Inc. and Microbion Corporation, a clinical-stage pharmaceutical company focused on the development of compounds for the treatment of resistant and difficult-to-treat infections, jointly announced today that the parties have entered into a strategic relationship for the development, manufacturing and commercial drug substance supply of Microbion’s new class of antibiotic and antibiofilm drugs.
5N Plus Expands its Active Pharmaceutical Ingredient (API) Portfolio to Include Compounds for a New Class of Antibiotic & Antibiofilm Drugs
Montreal, January 12, 2021 – 5N Plus Inc. announced today that it has entered into a strategic agreement with Bozeman, Montana-based Microbion Corporation, aimed at furthering the development of Microbion’s new class of antibiotic and antibiofilm drugs. Under the terms of the agreement, 5N Plus has taken an equity stake in Microbion and will assume responsibility for the manufacturing of Bismuth-based Active Pharmaceutical Ingredients (API) required in Microbion’s family of drug products currently under development, including Pravibismane, the API in the company’s lead drug product.
5N Plus Secures Multi-Year Semiconductor Supply Contracts in the Renewable Energy Sector
Montreal - November 12, 2020 – 5N Plus Inc. (TSX:VNP) announced today that it has secured multi-year contracts for the supply of semiconductor materials associated with the manufacturing of thin-film photovoltaic (PV) modules by First Solar, Inc. (Nasdaq: FSLR).
More news
© Copyright 2021 5N Plus - All Rights Reserved | Web Design by Akro. | Privacy Policy